Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FLT3 |
Variant | G846D |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | FLT3 G846D lies within the protein kinase domain of the Flt3 protein (UniProt.org). G846D confers a gain of function to Flt3 as demonstrated by IL3-independent growth and increased Stat5 phosphorylation in cultured cells (PMID: 38049555). |
Associated Drug Resistance | |
Category Variants Paths |
FLT3 mutant FLT3 act mut FLT3 G846D FLT3 mutant FLT3 exon20 FLT3 G846D |
Transcript | NM_004119.3 |
gDNA | chr13:g.28018471C>T |
cDNA | c.2537G>A |
Protein | p.G846D |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004119.2 | chr13:g.28018471C>T | c.2537G>A | p.G846D | RefSeq | GRCh38/hg38 |
NM_004119.3 | chr13:g.28018471C>T | c.2537G>A | p.G846D | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FLT3 G846D | hematologic cancer | sensitive | Midostaurin | Preclinical - Cell culture | Actionable | In a preclinical study, Rydapt (midostaurin) inhibited growth of cells expressing FLT3 G846D in culture (PMID: 38049555). | 38049555 |
FLT3 G846D | hematologic cancer | resistant | Sorafenib | Preclinical - Cell culture | Actionable | In a preclinical study, a cell line expressing FLT3 G846D was resistant to Nexavar (sorafenib) in culture (PMID: 38049555). | 38049555 |